Darnell Dent and Charles Stellar bring decades of experience to the healthcare technology company
STONY BROOK, N.Y., April 2, 2025 /PRNewswire/ — Softheon, a leading cloud-based shopping, eligibility, enrollment, billing, and member management solution for health plans, brokers, and government agencies, announced the election of Darnell Dent, founder and principal of Dent Advisory Services, LLC, and Charles Stellar, President & CEO of WEDI (Workgroup for Electronic Data Interchange), to its Board of Directors. Both leaders bring decades of experience to help guide Softheon as it continues innovating in healthcare technology.
“Darnell Dent and Charles Stellar have deep expertise in healthcare administration, organizational leadership, and strategic planning, and we are fortunate to have them join our Board of Directors,” said Eugene Sayan, founder and CEO of Softheon and its subsidiaries W3LL and CITIZ3N. “As we navigate the complex healthcare landscape and shifting federal policies, their guidance will help us develop cutting-edge solutions to make healthcare more affordable, accessible, and plentiful for every American.”
With extensive experience as the former CEO of four different managed healthcare companies, Dent brings exceptional insight into organizational and operational leadership. His collaborative approach to problem-solving has empowered and motivated executive teams and staff to achieve higher levels of performance. Dent is recognized for his proven leadership, strategic thinking, effective communication, and experience in the C-Suite and boardroom.
“What drew me to Softheon was seeing how the company helps address real problems facing health plans and the people they serve,” said Dent. “Having led multiple managed care organizations, I’ve seen firsthand how the right technology can transform operations and member experiences. I look forward to working with Softheon to further expand its impact on healthcare accessibility and affordability.”
Stellar has nearly four decades of expertise in health and hospital administration, association management, and organizational leadership. His work at WEDI has strengthened the organization’s role as an advisor to the Department of Health and Human Services, promoted innovative data exchange solutions, helped shape health IT standards, and advanced interoperability and the adoption of value-based care principles.
“Data exchange remains one of healthcare’s biggest challenges and opportunities,” said Stellar. “Softheon’s technology has turned this challenge into an advantage for its clients. This is just one of many challenges in healthcare that need leading-edge thinking and better solutions. I’m eager to work with my fellow board members and the Softheon team on new ways to help health plans serve their members and partners.”
These appointments align with Softheon’s ongoing work in cloud-based solutions for health plans, brokers, and government agencies. In turn, health plans can serve more people faster, help individuals find the right insurance, keep members engaged, and empower them to make healthier choices. Softheon’s subsidiary companies, CITIZ3N and W3LL, provide solutions for government agencies and enrollment partners, creating a unified health experience for all.
For more information about these solutions, visit www.softheon.com.
About Softheon
Founded in 2000, Softheon’s healthcare Software-as-a-Service (SaaS) and Business Process-as-a-Service (BPaaS) solutions solve complex challenges for health plans, their distribution networks, and government health agencies. Currently, Softheon’s solutions serve over 100 health plans. Issuers and consumers in Small Group, Medicare, and Affordable Care Act (ACA) markets benefit from Softheon’s technology that reduces administrative overhead and enhances user experiences. Softheon is an Agent and Merchant of Record that facilitates health insurance enrollment, administration, and renewal. For more information on Softheon’s solutions, visit www.Softheon.com.
Media Contact
PANBlast for Softheon
softheon@panblastPR.com
SOURCE Softheon
CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…
PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…